Bank of Nova Scotia’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,436
| Closed | -$664K | – | 1132 |
|
|
2022
Q1 | $664K | Sell |
27,436
-24,827
| -48% | -$601K | ﹤0.01% | 994 |
|
|
2021
Q4 | $1.22M | Buy |
52,263
+23,537
| +82% | +$551K | ﹤0.01% | 912 |
|
|
2021
Q3 | $477K | Buy |
28,726
+6,286
| +28% | +$104K | ﹤0.01% | 971 |
|
|
2021
Q2 | $547K | Buy |
+22,440
| New | +$547K | ﹤0.01% | 916 |
|